These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24786362)

  • 1. Subcellular localization and transport kinetics of ruthenium organometallic anticancer compounds in living cells: a dose-dependent role for amino acid and iron transporters.
    Klajner M; Licona C; Fetzer L; Hebraud P; Mellitzer G; Pfeffer M; Harlepp S; Gaiddon C
    Inorg Chem; 2014 May; 53(10):5150-8. PubMed ID: 24786362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
    Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
    Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
    Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis.
    Zheng W; Luo Q; Lin Y; Zhao Y; Wang X; Du Z; Hao X; Yu Y; Lü S; Ji L; Li X; Yang L; Wang F
    Chem Commun (Camb); 2013 Nov; 49(87):10224-6. PubMed ID: 23856988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
    Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
    Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents.
    Florindo PR; Pereira DM; Borralho PM; Rodrigues CM; Piedade MF; Fernandes AC
    J Med Chem; 2015 May; 58(10):4339-47. PubMed ID: 25923600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
    Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
    J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
    Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
    Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
    Selvamurugan S; Ramachandran R; Viswanathamurthi P
    Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
    Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
    Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules.
    Hanif M; Nazarov AA; Legin A; Groessl M; Arion VB; Jakupec MA; Tsybin YO; Dyson PJ; Keppler BK; Hartinger CG
    Chem Commun (Camb); 2012 Feb; 48(10):1475-7. PubMed ID: 22003496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells.
    Ballester FJ; Ortega E; Porto V; Kostrhunova H; Davila-Ferreira N; Bautista D; Brabec V; Domínguez F; Santana MD; Ruiz J
    Chem Commun (Camb); 2019 Jan; 55(8):1140-1143. PubMed ID: 30631876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
    Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug development.
    Babak MV; Meier SM; Legin AA; Adib Razavi MS; Roller A; Jakupec MA; Keppler BK; Hartinger CG
    Chemistry; 2013 Mar; 19(13):4308-18. PubMed ID: 23341078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
    Boff B; Gaiddon C; Pfeffer M
    Inorg Chem; 2013 Mar; 52(5):2705-15. PubMed ID: 23427955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents.
    Kasper C; Alborzinia H; Can S; Kitanovic I; Meyer A; Geldmacher Y; Oleszak M; Ott I; Wölfl S; Sheldrick WS
    J Inorg Biochem; 2012 Jan; 106(1):126-33. PubMed ID: 22115828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
    Fetzer L; Boff B; Ali M; Xiangjun M; Collin JP; Sirlin C; Gaiddon C; Pfeffer M
    Dalton Trans; 2011 Sep; 40(35):8869-78. PubMed ID: 21837342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.